Unknown PHASE4 INTERVENTIONAL 5-arm NCT02990403

The Novel Immunomodulatory and Anticoagulant Therapies for Recurrent Pregnancy Loss

Sponsor: Shanghai First Maternity and Infant Hospital

Interventions Aspirin Dydrogesterone Heparin Immunoglobulin Prednisone

Updated 8 times since 2017 Last updated: Mar 6, 2017 Started: Oct 31, 2014 Primary completion: Jun 10, 2017 Completion: Dec 22, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Recurrent Pregnancy Loss and is currently ongoing. Shanghai First Maternity and Infant Hospital leads this study, which shows 8 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jan 2019 — Jan 2021 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status
Jun 2018 — Jan 2019 [monthly]

Recruiting PHASE4

▶ Show 3 earlier versions

Mar 2017 — Jun 2018 [monthly]

Recruiting PHASE4
Feb 2017 — Mar 2017 [monthly]

Recruiting PHASE4
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE4

First recorded

Oct 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shanghai First Maternity and Infant Hospital

Data source: Shanghai First Maternity and Infant Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China